Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis’ Phase III Bone Drug Reclast Beats Actonel

Apr 14 2008

• By Brooke McManus

Related Content

Teva, Barr And Watson Launch Generics Of Merck’s Fosamax

Feb 06 2008

Reclast Approved For Once Yearly Treatment Of Postmenopausal Osteoporosis

Aug 20 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window